Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020
Revista Clínica Española · 2020-11 · 220 (8) · 463-471
DOI: 10.1016/j.rce.2020.05.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Clínica Española, 2020-11. Verfasst von V Suárez und 3 weiteren Autor:innen. Beteiligte Einrichtung: CONACyT - Universidad Autónoma Metropolitana-Iztapalapa, Departamento de Química, Ciudad de México, México. Die Arbeit wurde bisher 136-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: The first case of COVID-19 detected in Mexico was on the 27th of February 2020. On the 30th of April, 64 days after this first diagnosis, the number of patients had increased exponentially, reaching 19 224 confirmed cases and 1859 (9.67%) deaths. In response to this global outbreak, we summarize the current state of our understanding regarding COVID-19 in Mexico. METHODS: We obtained the data from the official website of the Ministry of Health in Mexico. The study period was between the 27th of February and the 30th of April 2020. The cases were confirmed using real-time reverse transcription-polymerase chain reaction, and we analysed epidemiological, demographic and clinical data. RESULTS: In Mexico, most cases of COVID-19 were located in Mexico City. The mean age of the patients was 46 years. Of the 12 656 confirmed cases, most infected individuals were between the ages of 30 and 59 years (65.85%), and there was a higher incidence rate in men (58.18%) than in women (41.82%). The patients who died had one or more comorbidities, mainly hypertension (45.53%), diabetes (39.39%) and obesity (30.4%). In the first 64 days of the epidemic, China had reported 80 304 cases with a mortality rate of 3.66%. CONCLUSIONS: Our results indicate an early transmission of COVID-19 in Mexico. The descriptive epidemiology shows similarities between the cases of COVID-19 in Mexico and those in China. In the same period of the epidemic curve, we observed a reduction in the number of confirmed cases of COVID-19 in Mexico and a higher mortality rate compared with that of China.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CONACyT - Universidad Autónoma Metropolitana-Iztapalapa, Departamento de Química, Ciudad de México, México.
- Unidad Profesional Interdisciplinaria de Ingeniería y Ciencias Sociales y Administrativas, Departamento de Química, Ciudad de México, México.
- Universidad Politécnica de Francisco I. Madero, Dirección de Ingeniería Agroindustrial, Hidalgo, México.
Zitieren
APA
Suárez, V., Suarez Quezada, M., Oros Ruiz, S., & Ronquillo De Jesús, E. (2020). Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020. Revista Clínica Española, 220(8), 463-471. https://doi.org/10.1016/j.rce.2020.05.007
Vancouver
Suárez V, Suarez Quezada M, Oros Ruiz S, Ronquillo De Jesús E. Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020. Revista Clínica Española. 2020;220(8):463-471. doi:10.1016/j.rce.2020.05.007
BibTeX
@article{Surez2020,
author = {Suárez, V and Suarez Quezada, M and Oros Ruiz, S and Ronquillo De Jesús, E},
title = {Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020},
journal = {Revista Clínica Española},
year = {2020},
volume = {220},
number = {8},
pages = {463--471},
doi = {10.1016/j.rce.2020.05.007}
}
EUVIMED